MALIGNANT MELANOMA STAGE I

MALIGNANT MELANOMA STAGE I was reported 272 times

MALIGNANT MELANOMA STAGE I is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Phosphodiesterase 5 Inhibitor [EPC] 97 0.0007
1 Tyrosine Kinase 2 Inhibitor [EPC] 1 0.0003
2 Vitamin D Analog [EPC] 5 0.0003
3 Provitamin D2 Compound [EPC] 5 0.0002
4 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 4 0.0001
5 Integrin Receptor Antagonist [EPC] 9 0.0001
6 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
7 Anti-anginal [EPC] 1 0.0001
8 Recombinant Human Growth Hormone [EPC] 2 0.0001
9 Alkaloid [EPC] 2 0.0001
10 Potassium-sparing Diuretic [EPC] 1 0.0001
11 Androgen [EPC] 2 0.0001
12 Sphingosine 1-phosphate Receptor Modulator [EPC] 1 0.0001
13 Interleukin-23 Antagonist [EPC] 7 0.0001
14 Muscle Relaxant [EPC] 3 0.0001
15 Nonergot Dopamine Agonist [EPC] 1 0.0001
16 B Lymphocyte Stimulator-specific Inhibitor [EPC] 2 0.0001
17 Interleukin-17A Antagonist [EPC] 2 0.0001
18 Aromatic Amino Acid [EPC] 3 0.0000
19 5-alpha Reductase Inhibitor [EPC] 5 0.0000
20 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1 0.0000
21 Calcineurin Inhibitor Immunosuppressant [EPC] 6 0.0000
22 Insulin [EPC] 2 0.0000
23 Progesterone [EPC] 1 0.0000
24 Interferon beta [EPC] 8 0.0000
25 Xanthine Oxidase Inhibitor [EPC] 7 0.0000
26 Folate Analog Metabolic Inhibitor [EPC] 17 0.0000
27 Tumor Necrosis Factor Blocker [EPC] 38 0.0000
28 Central alpha-2 Adrenergic Agonist [EPC] 2 0.0000
29 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2 0.0000
30 Anti-IgE [EPC] 3 0.0000
31 Nitrate Vasodilator [EPC] 3 0.0000
32 Sympathomimetic-like Agent [EPC] 1 0.0000
33 Purine Antimetabolite [EPC] 3 0.0000
34 Interleukin-12 Antagonist [EPC] 3 0.0000
35 Angiotensin 2 Receptor Blocker [EPC] 9 0.0000
36 Proteasome Inhibitor [EPC] 3 0.0000
37 Platelet Aggregation Inhibitor [EPC] 14 0.0000
38 Nonsteroidal Anti-inflammatory Drug [EPC] 31 0.0000
39 Thiazide-like Diuretic [EPC] 1 0.0000
40 Serotonin Reuptake Inhibitor [EPC] 2 0.0000
41 Pyrimidine Synthesis Inhibitor [EPC] 1 0.0000
42 CD20-directed Cytolytic Antibody [EPC] 7 0.0000
43 Dihydropyridine Calcium Channel Blocker [EPC] 7 0.0000
44 beta3-Adrenergic Agonist [EPC] 1 0.0000
45 Ester Local Anesthetic [EPC] 1 0.0000
46 Aminosalicylate [EPC] 2 0.0000
47 Thiazide Diuretic [EPC] 4 0.0000
48 Benzodiazepine [EPC] 11 0.0000
49 BCL-2 Inhibitor [EPC] 1 0.0000
50 Fluoroquinolone Antibacterial [EPC] 2 0.0000
51 Proton Pump Inhibitor [EPC] 9 0.0000
52 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
53 Interleukin-6 Receptor Antagonist [EPC] 2 0.0000
54 Calcium [EPC] 2 0.0000
55 Topoisomerase Inhibitor [EPC] 1 0.0000
56 Non-Standardized Chemical Allergen [EPC] 1 0.0000
57 Arteriolar Vasodilator [EPC] 1 0.0000
58 Vitamin B12 [EPC] 4 0.0000
59 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
60 Thalidomide Analog [EPC] 6 0.0000
61 Amide Local Anesthetic [EPC] 1 0.0000
62 Corticosteroid [EPC] 13 0.0000
63 Antiarrhythmic [EPC] 1 0.0000
64 Vitamin D [EPC] 3 0.0000
65 beta-Adrenergic Blocker [EPC] 3 0.0000
66 Expectorant [EPC] 2 0.0000
67 Vitamin C [EPC] 4 0.0000
68 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
69 Insulin Analog [EPC] 4 0.0000
70 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
71 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
72 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
73 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
74 Atypical Antipsychotic [EPC] 3 0.0000
75 Loop Diuretic [EPC] 3 0.0000
76 Aldosterone Antagonist [EPC] 1 0.0000
77 Azole Antifungal [EPC] 1 0.0000
78 Janus Kinase Inhibitor [EPC] 1 0.0000
79 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
80 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
81 Anti-epileptic Agent [EPC] 1 0.0000
82 Alkylating Drug [EPC] 1 0.0000
83 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
84 Osmotic Laxative [EPC] 1 0.0000
85 GLP-1 Receptor Agonist [EPC] 1 0.0000